Texas Capital Bancshares Inc Abbott Laboratories Transaction History

Texas Capital Bancshares Inc

$190 Million
Q3 2024

A detailed history of Texas Capital Bancshares Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Texas Capital Bancshares Inc holds 5,251 shares of ABT stock, worth $603,812. This represents 0.31% of its overall portfolio holdings.

Number of Shares

5,251

Previous 5,288 0.7%

Holding current value

$603,812

Previous $549,000 8.93%

% of portfolio

0.31%

Previous 0.23%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $3,702 - $4,370	-37 Reduced 0.7%	5,251 $598,000
Q2 2024 Aug 15, 2024	SELL	$100.73 - $112.44 $1,813 - $2,023	-18 Reduced 0.34%	5,288 $549,000
Q1 2024 May 13, 2024	BUY	$109.52 - $120.96 $5,037 - $5,564	46 Added 0.87%	5,306 $603,000
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $33,550 - $41,068	372 Added 7.61%	5,260 $578,000
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $191 - $229	2 Added 0.04%	4,888 $473,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $11,186 - $12,464	111 Added 2.32%	4,886 $532,000
Q1 2023 May 11, 2023	BUY	$96.86 - $114.01 $3,486 - $4,104	36 Added 0.76%	4,775 $483,000
Q4 2022 Feb 09, 2023	BUY	$95.06 - $111.52 $17,395 - $20,408	183 Added 4.02%	4,739 $520,000
Q3 2022 Nov 03, 2022	SELL	$96.76 - $112.03 $1,161 - $1,344	-12 Reduced 0.26%	4,556 $441,000
Q2 2022 Aug 04, 2022	SELL	$102.07 - $123.37 $1,326 - $1,603	-13 Reduced 0.28%	4,568 $496,000
Q4 2021 Feb 07, 2022	SELL	$115.53 - $141.46 $3,234 - $3,960	-28 Reduced 0.61%	4,581 $645,000
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $349 - $387	-3 Reduced 0.07%	4,609 $544,000
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $4,443 - $5,230	-42 Reduced 0.9%	4,612 $535,000
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $1,197 - $1,410	-11 Reduced 0.24%	4,654 $558,000
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $23,310 - $25,401	-222 Reduced 4.54%	4,665 $511,000
Q2 2020 Aug 03, 2020	SELL	$76.57 - $98.0 $43,108 - $55,174	-563 Reduced 10.33%	4,887 $447,000
Q4 2019 Jan 30, 2020	BUY	$78.51 - $87.4 $13,896 - $15,469	177 Added 3.36%	5,450 $473,000
Q3 2019 Oct 28, 2019	BUY	$81.84 - $88.74 $33,963 - $36,827	415 Added 8.54%	5,273 $441,000
Q1 2019 Apr 23, 2019	SELL	$66.22 - $80.06 $1,059 - $1,280	-16 Reduced 0.33%	4,858 $389,000
Q4 2018 Jan 29, 2019	SELL	$65.56 - $74.27 $39,139 - $44,339	-597 Reduced 10.91%	4,874 $352,000
Q2 2018 Jul 19, 2018	SELL	$57.57 - $63.54 $5,354 - $5,909	-93 Reduced 1.67%	5,471 $333,000
Q1 2018 Apr 25, 2018	SELL	$56.27 - $63.62 $21,213 - $23,984	-377 Reduced 6.35%	5,564 $333,000
Q4 2017 Jan 26, 2018	SELL	$53.68 - $57.47 $6,817 - $7,298	-127 Reduced 2.09%	5,941 $339,000
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $291,628 - $325,487	6,068	6,068 $324,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Capital Bancshares Inc, based on Form 13F filings with the SEC.

News

Stay updated on Texas Capital Bancshares Inc with notifications on news.

Account

Texas Capital Bancshares Inc Abbott Laboratories Transaction History